Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUROSUMAB-TWZA Cause Product availability issue? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Product availability issue have been filed in association with BUROSUMAB-TWZA. This represents 0.2% of all adverse event reports for BUROSUMAB-TWZA.

9
Reports of Product availability issue with BUROSUMAB-TWZA
0.2%
of all BUROSUMAB-TWZA reports
0
Deaths
0
Hospitalizations

How Dangerous Is Product availability issue From BUROSUMAB-TWZA?

Of the 9 reports.

Is Product availability issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUROSUMAB-TWZA. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does BUROSUMAB-TWZA Cause?

Inappropriate schedule of product administration (579) Blood phosphorus decreased (509) Product dose omission issue (475) Arthralgia (285) Pain (279) Pain in extremity (272) Headache (226) Restless legs syndrome (217) Incorrect dose administered (215) Injection site pain (205)

What Other Drugs Cause Product availability issue?

RUXOLITINIB (2,142) LISDEXAMFETAMINE DIMESYLATE (1,530) CERTOLIZUMAB PEGOL (1,381) VEDOLIZUMAB (636) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (610) METHYLPHENIDATE (444) SECUKINUMAB (399) BIMEKIZUMAB-BKZX (364) LACOSAMIDE (359) BRIVARACETAM (324)

Which BUROSUMAB-TWZA Alternatives Have Lower Product availability issue Risk?

BUROSUMAB-TWZA vs BUSPIRONE BUROSUMAB-TWZA vs BUSULFAN BUROSUMAB-TWZA vs BUSULFEX BUROSUMAB-TWZA vs BUTALBITAL BUROSUMAB-TWZA vs BUTENAFINE

Related Pages

BUROSUMAB-TWZA Full Profile All Product availability issue Reports All Drugs Causing Product availability issue BUROSUMAB-TWZA Demographics